接种疫苗
免疫
医学
不利影响
免疫系统
流感疫苗
临床疗效
免疫学
内科学
作者
Sachiko Hirobe,Hiroaki Azukizawa,Takaaki Hanafusa,Keitaro Matsuo,Ying‐Shu Quan,Fumio Kamiyama,Ichiro Katayama,Naoki Okada,Shinsaku Nakagawa
出处
期刊:Biomaterials
[Elsevier]
日期:2015-07-01
卷期号:57: 50-58
被引量:182
标识
DOI:10.1016/j.biomaterials.2015.04.007
摘要
Transcutaneous immunization (TCI) is an attractive vaccination method compared with conventional injectable vaccines because it is easier to administer without pain. We developed a dissolving microneedle patch (MicroHyala, MH) made of hyaluronic acid and showed that transcutaneous vaccination using MH induced a strong immune response against various antigens in mice. In the present study, we investigated the clinical safety and efficacy of a novel transcutaneous influenza vaccine using MH (flu-MH), which contains trivalent influenza hemagglutinins (15 μg each). Subjects of the TCI group were treated transcutaneously with flu-MH, and were compared with subjects who received subcutaneous injections of a solution containing 15 μg of each influenza antigen (SCI group). No severe local or systemic adverse events were detected in either group and immune responses against A/H1N1 and A/H3N2 strains were induced equally in the TCI and SCI groups. Moreover, the efficacy of the vaccine against the B strain in the TCI group was stronger than that in the SCI group. Influenza vaccination using MH is promising for practical use as an easy and effective method to replace conventional injections systems.
科研通智能强力驱动
Strongly Powered by AbleSci AI